PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
-
- Valentina Audrito
- Human Genetics Foundation (HuGeF), Turin, Italy
-
- Sara Serra
- Human Genetics Foundation (HuGeF), Turin, Italy
-
- Aureliano Stingi
- Human Genetics Foundation (HuGeF), Turin, Italy
-
- Francesca Orso
- Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
-
- Federica Gaudino
- Human Genetics Foundation (HuGeF), Turin, Italy
-
- Cinzia Bologna
- Human Genetics Foundation (HuGeF), Turin, Italy
-
- Francesco Neri
- Human Genetics Foundation (HuGeF), Turin, Italy
-
- Giulia Garaffo
- Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
-
- Romina Nassini
- Department of Health Sciences, University of Florence, Italy
-
- Gianna Baroni
- Department of Surgery and Translational Medicine, University of Florence, Italy
-
- Eliana Rulli
- Methodology for Clinical Research Laboratory, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
-
- Daniela Massi
- Department of Surgery and Translational Medicine, University of Florence, Italy
-
- Salvatore Oliviero
- Human Genetics Foundation (HuGeF), Turin, Italy
-
- Roberto Piva
- Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
-
- Daniela Taverna
- Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy
-
- Mario Mandalà
- Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy
-
- Silvia Deaglio
- Human Genetics Foundation (HuGeF), Turin, Italy
収録刊行物
-
- Oncotarget
-
Oncotarget 8 (9), 15894-15911, 2017-02-09
Impact Journals, LLC